The Centers for Medicare & Medicaid Services Friday finalized policy and technical changes to the Medicare Advantage and prescription drug benefit for contract year 2023. To improve MA plan oversight, the final rule would reinstate plan reporting on medical loss ratio requirements that were relaxed in 2017; require plans to demonstrate a sufficient provider network when applying for a new or expanded contract; strengthen CMS’s ability to evaluate plan performance when reviewing proposals for new or expanded contracts; require plans to provide certain materials to beneficiaries in culturally and linguistically appropriate ways; and strengthen oversight of third-party marketing organizations, among other consumer protection provisions. The rule also codifies provisions intended to improve and better assess quality for special needs plans that serve beneficiaries dually eligible for Medicare and Medicaid. 

Related News Articles

Headline
The Centers for Medicare & Medicaid Services yesterday finalized technical details regarding the Medicare Advantage Risk Adjustment Data Validation…
Headline
The Centers for Medicare & Medicaid Services yesterday released a proposed rule that would increase oversight of Medicare Advantage plans and better align…
Headline
The Centers for Medicare & Medicaid Services tonight released a proposed rule that would require Medicare Advantage, Medicaid and federally-facilitated…
Perspective
As Congress convenes for its post-election lame-duck session, we are turning up the pressure to secure additional support for hospitals and the patients and…
Perspective
There are many significant milestones in our nation’s history of voting. In 1776, America’s birth year, only white men age 21 and older who owned land were…
Headline
AHA today released a new report and infographic showing how some commercial health insurers, including Medicare Advantage plans, can cause dangerous delays in…